Drugs / N-pVAX1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06684431 | Nov 2024 → Mar 2026 | Crimean-Congo hemorrhagic fever | Karolinska Institutet | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-pVAX1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06684431 ↗ |
| Modality | Vaccine | “investigational vaccine N-pVAX1” NCT06684431 ↗ |
| Route | Intramuscular | “three im doses at weeks 0, 4 and 12” NCT06684431 ↗ |